The role of the endocannabinoid system in addictive behavior
2013; Wiley; Volume: 18; Issue: 6 Linguagem: Inglês
10.1111/adb.12115
ISSN1369-1600
Autores Tópico(s)Sleep and Wakefulness Research
ResumoAddiction BiologyVolume 18, Issue 6 p. 904-907 COMMENTARY The role of the endocannabinoid system in addictive behavior Ainhoa Bilbao, Ainhoa Bilbao [email protected] Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, GermanySearch for more papers by this author Ainhoa Bilbao, Ainhoa Bilbao [email protected] Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, GermanySearch for more papers by this author First published: 28 November 2013 https://doi.org/10.1111/adb.12115Citations: 8Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Agrawal A, Lynskey MT, Hinrichs A, Grucza R, Saccone SF, Krueger R, Neuman R, Howells W, Fisher S, Fox L, Cloninger R, Dick DM, Doheny KF, Edenberg HJ, Goate AM, Hesselbrock V, Johnson E, Kramer J, Kuperman S, Nurnberger JI Jr., Pugh E, Schuckit M, Tischfield J, Geneva Consortium, Rice JP, Bucholz KK, Bierut LJ (2011) A genome-wide association study of DSM-IV cannabis dependence. Addict Biol 16: 514–518. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094–1097. Benyamina A, Kebir O, Blecha L, Reynaud M, Krebs MO (2011) CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol 16: 1–6. Bilbao A (2013) Advanced transgenic approaches to understand alcohol-related phenotypes in animals. Curr Top Behav Neurosci 13: 271–311. Cadas H, Gaillet S, Beltramo M, Venance L, Piomelli D (1996) Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J Neurosci 16: 3934–3942. Cooper ZD, Foltin RW, Hart CL, Vosburg SK, Comer SD, Haney M (2013) A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addict Biol 18: 993–1002. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Porrino LJ, Goudriaan AE (2013) Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addict Biol 18: 1013–1023. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83–87. Crunelle CL, van de Giessen E, Schulz S, Vanderschuren LJ, de Bruin K, van den Brink W, Booij J (2013) Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. Addict Biol 18: 908–911. Devane WA, Dysarz FA 3rd, Johnson M, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605–613. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686–691. Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21: 521–528. Euser AS, Evans BE, Greaves-Lord K, Huizink AC, Franken IH (2013) Diminished error-related brain activity as a promising endophenotype for substance-use disorders: evidence from high-risk offspring. Addict Biol 18: 970–984. Fehr KA, Kalant H, LeBlanc AE (1976) Residual learning deficit after heavy exposure to cannabis or alcohol in rats. Science 192: 1249–1251. Gamaleddin I, Wertheim C, Zhu AZ, Coen KM, Vemuri K, Makryannis A, Goldberg SR, Le Foll B (2012) Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking. Addict Biol 17: 47–61. Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646–1647. Helinski S, Spanagel R (2011) Publication trends in addiction research. Addict Biol 16: 532–539. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563–583. Justinová Z, Ferré S, Redhi GH, Mascia P, Stroik J, Quarta D, Yasar S, Müller CE, Franco R, Goldberg SR (2011) Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist. Addict Biol 16: 405–415. Le Merrer J, Befort K, Gardon O, Filliol D, Darcq E, Dembele D, Becker JA, Kieffer BL (2012) Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. Addict Biol 17: 1–12. Leroy C, Karila L, Martinot JL, Lukasiewicz M, Duchesnay E, Comtat C, Dollé F, Benyamina A, Artiges E, Ribeiro MJ, Reynaud M, Trichard C (2012) Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict Biol 17: 981–990. Llorente-Berzal A, Fuentes S, Gagliano H, López-Gallardo M, Armario A, Viveros MP, Nadal R (2011) Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behavior. Addict Biol 16: 624–637. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564. McPartland J, Matias I, Di Marzo V, Glass M (2006) Evolutionary origins of the endocannabinoid system. Gene 370: 64–74. Méndez-Díaz M, Rueda-Orozco PE, Ruiz-Contreras AE, Prospéro-García O (2012) The endocannabinoid system modulates the valence of the emotion associated to food ingestion. Addict Biol 17: 725–735. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kamisnki NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83–90. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61–65. Schneider M (2008) Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 13: 253–263. Simonnet A, Cador M, Caille S (2013) Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area. Addict Biol 18: 930–936. Sturgess JE, George TP, Kennedy JL, Heinz A, Müller DJ (2011) Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addict Biol 16: 357–376. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215: 89–97. Vandrey R, Haney M (2009) Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs 23: 543–553. Verweij KJ, Zietsch BP, Liu JZ, Medland SE, Lynskey MT, Madden PA, Agrawal A, Montgomery GW, Heath AC, Martin NG (2012) No association of candidate genes with cannabis use in a large sample of Australian twin families. Addict Biol 17: 687–690. Vinod KY, Maccioni P, Garcia-Gutierrez MS, Femenia T, Xie S, Carai MA, Manzanares J, Cooper TB, Hungund BL, Colombo G (2012) Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats. Addict Biol 17: 62–75. Winsauer PJ, Daniel JM, Filipeanu CM, Leonard ST, Hulst JL, Rodgers SP, Lassen-Greene CL, Sutton JL (2011) Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status. Addict Biol 16: 64–81. Citing Literature Volume18, Issue6November 2013Pages 904-907 ReferencesRelatedInformation
Referência(s)